Press release
Rising Dengue Incidence Driving Growth In The Market Driver: A Major Catalyst in the Evolution of the Dengue Treatment Market in 2025
Dengue Treatment Market Size
In recent times, the market for dengue treatment has witnessed a rapid expansion. It is projected to rise from $2.10 billion in 2024 to $2.35 billion in 2025, with a compound annual growth rate (CAGR) of 12.0%. The surge experienced in the past can be credited to the enhancement of diagnostic tools, interventions from government and NGOs, the presence of advanced epidemiological surveillance systems, substantial r&d investments, and initiatives for community education.
Anticipated to experience swift expansion in the upcoming years, the dengue treatment market is projected to balloon to $3.64 billion by 2029, boasting a compound annual growth rate (CAGR) of 11.6%. The predicted growth during this forecasting period can be linked to factors such as the development of universal vaccines, increased availability of vaccines, collaborations between public and private sectors, the boom in telemedicine, and improvements in policy frameworks. Key trends forecasted for this period encompass the advent of next-generation dengue vaccines, drug discovery via artificial intelligence, intelligent contact tracing methods, 3D-printed vaccines, and the use of CRISPR for targeting viruses.
What Are the Key Drivers Behind the Growth of the Dengue Treatment Market?
The escalation in the number of dengue cases is predicted to drive the expansion of the dengue treatment market. Dengue is a viral infection transmitted by mosquitos, inducing symptoms similar to flu, and may lend itself to serious complications if not addressed. Primarily, the surge in dengue cases can be attributed to various factors like intensified urbanization, climatic changes promoting mosquito breeding, deficient control measures for the vector, and an expanding population in areas prone to high-risk. Dengue treatment helps in slashing down the occurrence rate of dengue by providing immediate medical assistance, easing severe symptoms, warding off potential complications, and stemming the spread of the disease through improved patient results and raised public health consciousness. For instance, a report issued by the Centers for Disease Control and Prevention, a US government organization, in 2023, stated that dengue fever instances in the Americas had spiked to in excess of 4.6 million, with around 4,000 fatalities, indicating a 13% upsurge compared to the same timeframe in 2022, and a notable leap from prior years. Hence, the hike in dengue case rate fuels the growth of the dengue treatment market.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20745&type=smp
Who Are the Major Industry Players Fueling Dengue Treatment Market Expansion?
Major companies operating in the dengue treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co Inc., Sanofi S.A., Abbott Laboratories, Novartis International AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim GmbH, Hetero Labs Limited, Sun Pharmaceutical Industries Limited, Dr. Reddy's Laboratories Limited, Cipla Incorporated, Emergent BioSolutions Inc., Bharat Biotech International Limited, Inovio Pharmaceuticals Inc., Gennova Biopharmaceuticals Ltd., ABIVAX S.A., Cadila Healthcare Limited, Biological E. Limited
How Is the Dengue Treatment Market Evolving?
Leading organizations in the dengue treatment industry are concentrating their efforts on the creation of solutions like broad-spectrum antiviral medicines in order to increase treatment effectiveness, minimize the severity of the illness, and tackle numerous dengue virus serotypes at once. A broad-spectrum antiviral medication is a type of drug that can combat multiple viruses instead of only one specific type. For instance, in September 2024, Hyundai Pharmaceutical Co. Ltd., a pharmaceutical product manufacturer from South Korea, introduced XAFTY, a groundbreaking broad-spectrum antiviral drug meant to cure various viral diseases, including COVID-19 and dengue fever. This novel drug introduces unique properties, such as the enhancement of the absorption and potency of niclosamide, proven safety and efficiency proven through clinical trials, the capacity to combat several RNA viruses, versatility against potential future risks, and a rapid action potential that facilitates the fast distribution to areas dealing with public health emergencies.
How Is the Segmentation of the Dengue Treatment Market Defined?
The dengue treatment market covered in this report is segmented -
1) By Type: Vaccines, Acetaminophen
2) By Route Of Administration: Parenteral, Oral
3) By Drug Class: Nsaids, Antibiotics, Corticosteroids
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
5) By End User: Hospital, Specialty Clinics, Home Healthcare
Subsegments:
1) By Vaccines: Live Attenuated Vaccines, Recombinant Vaccines, Inactivated Vaccines
2) By Acetaminophen: Oral Acetaminophen, Intravenous Acetaminophen
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/dengue-treatment-global-market-report
What Is the Leading Region in the Dengue Treatment Market?
Asia-Pacific was the largest region in the dengue treatment in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dengue treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Is Covered In The Dengue Treatment Global Market Report?
- Market Size Analysis: Analyze the dengue treatment Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the dengue treatment Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the market.
- Market Contribution: Evaluate contributions of different segments to the overall dengue treatment market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the dengue treatment market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20745
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Dengue Incidence Driving Growth In The Market Driver: A Major Catalyst in the Evolution of the Dengue Treatment Market in 2025 here
News-ID: 3876678 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Dengue
Key Trend Reshaping the Dengue Treatment Market in 2025: Innovative Drug Deliver …
Which drivers are expected to have the greatest impact on the over the dengue treatment market's growth?
The escalation in cases of dengue is projected to stimulate the expansion of the market for dengue treatments. Dengue is a viral infection transmitted by mosquito bites, causing symptoms akin to the flu and can escalate to intense complications if not treated. The escalation is primarily due to progressing urbanization, climate alterations favourable to…
Key Dengue Vaccine Market Trend for 2025-2034: Advancements In Dengue Tetravalen …
What Is the Future Outlook for the Dengue Vaccine Market's Size and Growth Rate?
In the past few years, the dengue vaccine market has experienced significant growth. From $0.64 billion in 2024, it is projected to reach $0.72 billion in 2025, marking a compound annual growth rate (CAGR) of 12.4%. This notable expansion during the historical period can be credited to factors such as an increase in travel and urbanization trends,…
Dengue Vaccine Market : An Detailed Overview
Introduction:
Dengue fever is a mosquito-borne viral infection caused by the dengue virus, transmitted primarily through Aedes aegypti and Aedes albopictus mosquitoes. Affecting millions globally each year, dengue has become a significant public health concern, especially in tropical and subtropical regions. The development of dengue vaccines represents a groundbreaking advancement in preventing the disease, reducing its associated healthcare costs, and controlling outbreaks. With increasing awareness and investments in immunization programs, the…
Dengue Vaccine Market : An Overview
Introduction:
Dengue fever is a mosquito-borne viral infection that has become a significant public health challenge in tropical and subtropical regions. The disease is caused by the dengue virus, which is transmitted primarily by Aedes aegypti mosquitoes. With approximately 390 million infections annually, dengue fever places a substantial burden on healthcare systems and economies worldwide. Efforts to mitigate this burden have led to the development of dengue vaccines, designed to prevent…
"Rising Incidence of Dengue Fever Propels Dengue Virus Diagnostic Tests Market T …
According to WHO, dengue affects about 50-100 million people worldwide, annually. It is a vector-borne highly communicable disease. This report discusses the diagnostic tests used to confirm the presence of dengue in one individual.
It is true that the growth of the global dengue virus diagnostic tests market is primarily driven by an increase in the incidence of dengue fever, which is a mosquito-borne viral infection that can cause severe flu-like…
Dengue Vaccines Market 2021 | Detailed Report
Dengue Vaccines Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027.
Get Free Sample PDF (including full TOC, Tables and Figures) of Dengue Vaccines Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4644240
The report provides a comprehensive analysis of company profiles listed below:
- Sanofi
- Takeda
Dengue Vaccines Market Segment by…
